23 24 Multiple nuclear receptors including hepatocyte nuclear factor 4α (HNF4α), 25 retinoid X receptor α (RXRα) plus peroxisome proliferator-activated receptor α 26
Hepatitis B virus (HBV) biosynthesis is primarily restricted to the liver (15). This 46 tropism presumably reflects the limited tissue distribution of the viral receptor although 47 the entry mechanism and proteins involved have not been defined (12). However, the 48 tissue tropism of HBV is also restricted at the level of transcription (15). Liver-enriched 49 transcription factors, and nuclear receptors in particular, have been shown to be essential 50 for viral RNA synthesis (19, 44, 47, 52, 53, 61) . As HBV replicates by the reverse 51 transcription of the pregenomic 3.5kb RNA synthesized from the nucleocapsid or core 52 promoter (58), it is apparent that transcription is a major regulatory step governing viral 53 biosynthesis (53). In the context of viral replication the nuclear receptors, HNF4α, 54
RXRα plus PPARα, RXRα plus FXRα, LRH1 and ERR have been shown to be the only 55 transcription factors capable of supporting pregenomic RNA synthesis and viral 56 replication in nonhepatoma cells in the absence of any additional complementing 57 transcriptional regulatory machinery (44, 53) . These observations suggest that nuclear 58 receptors have a unique capacity to support HBV transcription and replication. However, 59 the relative importance of the various nuclear receptors in governing HBV biosynthesis in 60 vivo has not been extensively investigated (14, 24) . Additionally the coactivator, 61 peroxisome proliferator-activated receptor γ coactivator 1α (PGC1α), and the 62 corepressor, small heterodimer partner (SHP), differentially modulate nuclear receptor 63 activities and appear to represent important regulators of HBV biosynthesis (34-36). 64
The HBV transgenic mouse model of chronic viral infection has been used to 65 examine the in vivo role of PPARα and HNF4α in HBV transcription and replication 66 (14, 24) . Under normal physiological conditions, PPARα did not influence HBV 67 biosynthesis but activation of PPARα by synthetic ligands did lead to enhanced viral 68 biosynthesis (14) . These observations demonstrated that PPARα can modulate HBV 69 RNA and DNA synthesis under conditions where PPARα is activated by an appropriate 70 small molecule (14, 42) . In contrast to PPARα, HNF4α was shown to be essential for the 71 developmental expression of HBV transcripts in the liver and hence viral biosynthesis 72 (24, 42) . Although HNF4α can support HBV biosynthesis in nonhepatoma cell lines and 73 is essential for viral transcription and replication during liver development, it is unclear 74 that this nuclear receptor alone governs HBV production in vivo (24, 44, 53 The production and characterization of the HBV transgenic mouse lineage 1.3.32 109 has been described (15). These HBV transgenic mice contain a single copy of the 110 terminally redundant, 1.3-genome length copy of the HBVayw genome integrated into 111 the mouse chromosomal DNA. High levels of HBV replication occur in the livers of 112 these mice. The mice used in the breeding experiments were homozygous for the HBV 113 transgene and were maintained on the SV129 genetic background (22). 114
The production and characterization of the SHP-null mice has been described 115 (55,56). These mice do not express SHP which contributes to bile acid and cholesterol 116 homeostasis (55,56). The mice used in the breeding experiments were homozygous null 117 for SHP and maintained on the C57B1/129SV hybrid genetic background (55,56). 118 SHP-null HBV transgenic mice were generated by mating the HBV transgenic 119 mice with the SHP-null (-/-) mice. The resulting SHP heterozygous (+/-) HBV 120 transgenic F 1 mice were subsequently mated with the SHP-null (-/-) mice and the F 2 mice 121 were screened for the HBV transgene and SHP-null allele by polymerase chain reaction 122 (PCR) analysis of tail DNA. Tail DNA was prepared by incubating 1 cm of tail in 500 μl 123 of 100 mM Tris hydrochloride (pH 8.0), 200 mM NaCl, 5 mM EDTA, 0.2% (wt/vol) 124 SDS containing 100 μg/ml Proteinase K for 16 to 20 hours at 55°C. Samples were 125 centrifuged at 14,000 rpm in an Eppendorf 5417C microcentrifuge for 10 minutes and the 126 supernatant was precipitated with 500 μl of isopropanol. DNA was pelleted by 127 centrifugation at 14,000 rpm in an Eppendorf 5417C microcentrifuge for 10 minutes and 128 subsequently dissolved in 100 μl of 5 mM Tris hydrochloride (pH 8.0), 1 mM EDTA. 129
The HBV transgene was identified by PCR analysis using the oligonucleotides, 5'- The samples were subjected to 42 amplification cycles involving denaturation at 94°C for 142 1 minute, annealing at 55°C for 1 minute, and extension from the primers at 72°C for 2 143 minutes. The 20 μl reaction conditions used were as described by the manufacturer 144 HBeAg analysis was performed using 2 μl of mouse serum and the HBe enzyme 188 linked immunosorbent assay as described by the manufacturer (Epitope Diagnostics). 189
The level of antigen was determined in the linear range of the assay. Alanine 190 aminotransferase (ALT) activity was determined using 10 μl of mouse serum as 191 described by the manufacturer (Genzyme). The level of ALT was determined in the 192 linear range of the assay using an ALT positive control (Cayman Chemical). 193
Plasmid constructions. 194
The steps in the cloning of the plasmid constructs used in the transfection 195 experiments were performed by standard techniques (46). HBV DNA sequences in these 196 constructions were derived from the plasmid pCP10, which contains two copies of the 197 HBV genome (subtype ayw) cloned into the EcoRI site of pBR322 (9). The HBV DNA 198 (4.1kbp) construct that contains 1.3 copies of the HBV genome includes the viral 199 sequence from nucleotide coordinates 1072 to 3182 plus 1 to 1990 ( Fig. 1A ). This The pCMVHNF4α, pRS-hRXRα and pCMV-rFXRα vectors express HNF4α, 207
RXRα and FXRα polypeptides from the rat HNF4α, human RXRα and rat FXRα 208 cDNAs, respectively, using the CMV immediate-early promoter (pCMV) and the Rous 209 sarcoma virus LTR (pRS) (6,28,31). 210
Cells and transfections. 211
The human embryonic kidney 293T cell line was grown in RPMI-1640 medium 212 and 10% fetal bovine serum at 37°C in 5% CO 2 /air. Transfections for viral RNA and 213 DNA analysis were performed as previously described (32) using 10 cm plates, 214 containing approximately 1 X 10 6 cells. DNA and RNA isolation was performed 3 days 215 post transfection. The transfected DNA mixture was composed of 5 μg of HBV DNA 216 mice was examined. As SHP expression is activated by FXR and it is a negative 265 regulator of nuclear receptor-mediated transcription (13,28), it could potentially be an in 266 vivo inhibitor of bile acid-and nuclear receptor-mediated HBV transcription and 267 replication ( Fig. 1) (35-37) . 268 generation. In these studies, both SHP-expressing and SHP-null HBV transgenic mice 274 were fed a diet supplemented with 1% (wt/wt) cholic acid for 7 days (56). Male and 275 female mice of each genotype were assayed for the levels of liver SHP, FXRα, BSEP, 276 CYP7A1 and PGC1α RNAs after bile acid feeding and compared with animals fed a 277 control diet (Fig. 2) . As expected, mice heterozygous for the SHP-expressing allele 278
Effect of bile acid feeding on FXR and SHP regulated gene expression in SHP-
displayed an approximately two-fold induction of SHP RNA after bile acid feeding ( Fig.  279 2A) (56). SHP-null HBV transgenic mice did not express SHP RNA ( Fig. 2A) . In both 280 male and female HBV transgenic mice, the abundance of the FXRα RNA appeared to be 281 very modestly increased due to the absence of SHP (Fig. 2B) . Importantly, the inclusion 282 of cholic acid in the diet was associated with a decrease in FXRα transcript levels as 283 previously noted (56). Additionally, cholic acid appeared to induce the expression of the 284 bile salt export pump (BSEP) transcript in SHP-expressing HBV transgenic mice and this 285 induction was not apparent in the SHP-null HBV transgenic mice ( Fig. 2C ) (56). Most 286 notably, feeding mice a diet which included cholic acid resulted in a dramatic inhibition 287 of CYP7A1 expression that was relieved to a limited extent in the SHP-null mice ( Fig.  288 2D) (56). These observations clearly indicate that the cholic acid diet was effectively 289 modulating FXR and SHP activities in the liver in an attempt to maintain normal bile acid 290 homeostasis as previously noted (Fig. 1) (28,56) . As PGC1α is a coactivator that can 291 counteract the effect of SHP on HBV biosynthesis in cell culture (35,36) and its 292 expression has previously been shown to be down regulated in vivo by bile acids (29), the 293 effect of feeding cholic acid on this transcript was examined in the HBV transgenic mice 294 ( Fig. 2E ). Contrary to previous observations, cholic acid treatment did not display any 295 consistent effects on PGC1α RNA levels in these mice suggesting this coactivator 296 probably does not play a role in modulating the level of HBV biosynthesis under these 297 particular physiological circumstances. The reason PGC1α RNA levels were unaffected 298 in the HBV transgenic mice is unclear but may reflect differences in the genetic 299 backgrounds of the mice used in the various studies or the methods used to measure the 300 levels of the PGC1α transcript. 301 expressing and SHP-null HBV transgenic mice were only statistically significant in the 312 male mice (Fig. 3A) . As HBeAg is translated from the HBV 3.5kb precore RNA (57), 313 these observations suggest that the diet supplemented with cholic acid may have a modest 314 effect on the synthesis of the HBV 3.5kb precore RNA in the HBV transgenic mice. 315
Effect of bile acid feeding on serum HBeAg, liver damage and inflammation in HBV
As bile acid feeding can be associated with hepatic cytotoxicity (55), the levels of 316 serum alanine aminotransaminase (ALT) were examined (Fig. 3B) . Indeed, the bile acid 317 fed mice displayed a marked increase in serum ALT which appeared more pronounced in 318 the male SHP-null HBV transgenic mice. The peak serum ALT level was observed 319 between days 4 and 6 and declined up to two-fold by day 7 suggesting there was a 320 protective homeostatic adjustment to increased bile acid intake occurring in the liver 321 (28,56). The observed elevation in serum ALT raised the possibility that the increase in 322 serum HBeAg observed in the cholic acid treated HBV transgenic mice might be due to 323 the destruction of hepatocytes replicating virus, although histological examination of 324 these livers appeared normal. Indeed, chemically-induced liver damage in HBV 325 transgenic mice is associated with an increase in both serum ALT and HBeAg levels 326 (V.C. Reese and A. McLachlan, unpublished data). In addition, it was possible that 327 hepatic cell death might be associated with increased inflammation although leukocyte 328 infiltrates were not observed in these livers. To examine the possibility that hepatic 329
Kupffer cells were becoming activated as a result of hepatic damage, the level of TNFα 330 RNA in the livers of these mice was measured (Fig. 3C ). No significant elevation in 331 TNFα gene expression was observed indicating the absence of any inflammatory 332 response in the liver in response to the cholic acid diet. 333
Effect of bile acid feeding on viral transcription in HBV transgenic mice. 334
HBV transgenic mice that were heterozygous or homozygous for the SHP-null 335 allele were examined for their steady state levels of HBV transcripts by analysis of the 336 total liver RNA (Fig. 4) . The steady state levels of the HBV 3.5-and 2.1kb transcripts in 337 the livers of the HBV transgenic mice with and without SHP were not greatly influenced 338 by the cholic acid diet (Fig. 4) . Measurement of the levels of the HBV 3.5kb transcripts 339 indicated they were increased about 1.9-fold by the cholic acid diet in male SHP-340 expressing HBV transgenic mice based on the RNA filter hybridization (Fig. 4B) and 341 RT-qPCR analysis (Fig. 4C ). These observations are consistent with the suggestion that 342 bile acids activate FXR leading to increase transcription from the HBV nucleocapsid 343 promoter ( Fig. 1) (35,40,44 ). In the male SHP-null HBV transgenic mice, the levels of 344 the HBV 3.5kb transcripts were 2.8-and 1.3-fold higher than those observed in the SHP-345 expressing male HBV transgenic mice based on the RNA filter hybridization (Fig. 4B)  346 and RT-qPCR analysis (Fig. 4C) . These observations are consistent with the suggestion 347 that under normal physiological conditions SHP can modestly suppress nuclear receptor-348 mediated transcription from the HBV nucleocapsid promoter ( Fig. 1) (35-37) . Male 349 SHP-null HBV transgenic mice fed the cholic acid diet did not display a greater increase 350 in the HBV 3.5kb transcripts than the SHP-expressing HBV transgenic mice fed the 351 cholic acid diet or the SHP-null HBV transgenic mice fed the control diet suggesting that 352 the activation of FXR by bile acids in the absence of the nuclear receptor corepressor, 353 SHP, did not lead to an enhanced effect on HBV transcription as might have been 354 predicted (Fig. 1) . In female HBV transgenic mice, it was interesting to note that neither 355 the cholic acid diet nor the absence of SHP increased the level of the HBV 3.5kb 356 transcripts suggesting this transcriptional response to bile acids may be sexually 357 dimorphic in nature in the liver (Fig. 4) . 358
Effect of bile acid feeding on viral replication intermediates in HBV transgenic 359

mice. 360
The alterations in the levels of replication intermediates in the livers of SHP-361 expressing and SHP-null HBV transgenic mice on control or cholic acid diets closely 362 paralleled the observed changes in HBV 3.5kb RNA abundances ( Figs. 4 and 5) . 363
Measurement of the levels of the HBV replication intermediates indicated they were 364 increased about 1.3-fold by the cholic acid diet in male SHP-expressing HBV transgenic 365 mice based on the DNA filter hybridization analysis (Fig. 5B ). In the male SHP-null 366 HBV transgenic mice, the levels of the HBV replication intermediates were 2.3-fold 367 higher than those observed in the SHP-expressing male HBV transgenic mice based on 368 the DNA filter hybridization analysis (Fig. 5B) . These observations are consistent with 369 the transcriptional analysis ( Fig. 4) and suggest that cholic acid may activate and SHP 370 may inhibit HBV 3.5kb RNA synthesis from the HBV nucleocapsid promoter to 371 modulate HBV biosynthesis ( Fig. 1) (35-37) . As observed with the HBV 3.5kb RNA 372 synthesis, female HBV transgenic mice displayed very limited, statistically insignificant, 373 alterations in viral replication intermediates in response to the cholic acid diet or the loss 374 of SHP (Fig. 5) . These observations suggest that the transcriptional regulatory network 375 involving FXR and SHP which helps to maintain bile acid homeostasis within the liver 376 (13,28) may preferentially modulate HBV transcription and replication in males, possibly 377 contributing to the greater disease burden in men relative to women associated with 378 chronic HBV infection (21, 27, 60) . 379
Absence of synergistic modulation of HNF4 and FXRα directed HBV biosynthesis in 380 human embryonic kidney 293T cells 381
Bile acid feeding in the presence or absence of SHP has a modest effect on viral 382 transcription and replication in male HBV transgenic mice and essentially no effect on 383 viral biosynthesis in female HBV transgenic mice (Figs. 4 and 5 ). This appears contrary 384 to the effects observed in cell culture where FXR and SHP can greatly modulate HBV 385 biosynthesis (35-37,44). However to more closely approximate the conditions observed 386 in vivo, the consequence of expressing multiple nuclear receptors on HBV biosynthesis 387 was investigated in nonhepatoma cells (Fig. 6) . Transfection of the replication competent 388 HBV DNA (4.1kbp) construct alone into 293T cells untreated or treated with bile acid 389 failed to support viral biosynthesis (Fig. 6, lane 1 and 2) . Transfection of the HBV DNA 390 (4.1kbp) construct with an HNF4 expression vector in the absence, or presence, of bile 391 acid supported HBV transcription and replication (Fig. 6, lane 3 and 4) . Transfection of 392 the HBV DNA (4.1kbp) construct with a RXRα plus FXRα expression vector in the 393 presence, but not in the absence, of bile acid supported robust HBV transcription and 394 replication (Fig. 6, lane 5 and 6) . Critically, transfection of the HBV DNA (4.1kbp) 395 construct with an HNF4, RXRα and FXRα expression vectors in the presence of bile 396 acid supported a level of HBV transcription and replication that was similar to that 397 observed with HNF4 or RXRα plus FXRα expression vectors alone (Fig. 6, lane 8) . 398
This indicates that HNF4 and RXRα plus FXRα do not synergistically or even additively 399 cooperate to promote HBV transcription. This observation may explain the limited effect 400 of bile acid treatment on HBV biosynthesis in the HBV transgenic mice. HNF4, and 401 other nuclear receptors such as LRH1 and ERR, which are capable of supporting HBV 402 biosynthesis are constitutively expressed in the liver. Activation of FXR by bile acids 403 must compete with these additional nuclear receptors to activate transcription from the 404 HBV nucleocapsid promoter ( Fig. 1) . Based on the cell culture analysis (Fig. 6) , it is 405 possible that in vivo even the activation of FXR by bile acids is not sufficient to further 406 enhance HBV transcription and replication which is being directed by the constitutively 407 active nuclear receptors such as HNF4 that appear to be essential for viral biosynthesis 408 ( Fig. 1) (24) . Interestingly the expression of HNF4 and RXRα plus FXRα in the 409 absence of bile acid appears to support less HBV RNA and DNA synthesis than observed 410 with HNF4 alone (Fig. 6, lanes 3, 5 and 7) suggesting that RXRα plus FXRα in the 411 absence of ligand may actually inhibit HNF4-mediated viral biosynthesis, presumably by 412 competing for the proximal nuclear receptor binding site in the HBV nucleocapsid 413 promoter (40, 42, 44) . RXRα plus PPARα, RXRα plus FXRα, LRH1 and ERR, have been shown to be capable 436 of supporting HBV biosynthesis in nonhepatoma cells ( Fig. 1) (44,53) . network in male and female mice ( Fig. 1) (13,28) . The reasons for these differences are 460 currently unclear but it is worth noting that disease progression is generally more severe 461 in males than females indicating there are sexually dimorphic differences present both in 462 mice and man (21, 27, 60) . 463
In an attempt to explain the very modest effect of FXR activation on HBV 464 biosynthesis in vivo, the relative importance of HNF4 and RXRα plus FXRα was 465 examined in nonhepatoma cells (Fig. 6 ). Previously, it has been shown that both these 466 nuclear receptors can direct the expression of HBV 3.5kb RNA and hence viral 467 replication (35, 36, 44, 53) . Notably, the simultaneous expression of both these nuclear 468 receptors does not lead to any enhancement of HBV RNA and DNA synthesis over that 469 seen with the transcription factors alone (Fig. 6 ). The absence of any additive or 470 synergistic effects on viral biosynthesis in cell culture suggests an explanation for the 471 lack of any major effect of the bile acid diet in vivo (Figs. 4 and 5) . In the liver, HNF4 is 472 presumably constitutively active. Activation of FXR by the bile acid diet clearly altered 473 the expression of both FXR and SHP target genes as expected ( Figs. 1 and 2) (13, 28, 29) . 474 However, activated FXR had only a minimal effect on HBV biosynthesis presumably 475 because it cannot efficiently enhance HNF4-mediate HBV nucleocapsid promoter 476 activity (Fig. 6 ). The ability of FXR to modestly increase viral biosynthesis in male mice 477 but not in female mice may reflect subtle differences in the nature of the transcription 478 factors governing HBV nucleocapsid promoter activity in the different sexes. Regardless 479 of these differences, it is important to note that the HBV transgenic mouse model reflects 480 only the changes in expression associated with a single viral replication cycle and even a 481 small difference in replication efficiency can lead to a dramatic amplification in viral titer 482 over an infection period that represents many replication cycles. Therefore it is possible 483 that bile acid metabolism in the liver might contribute to some of the difference in viral 484 synthesis and disease outcomes associated with HBV infections in men and women ( 
